Cargando…
The Streptococcus pyogenes vaccine landscape
Recent efforts have re-invigorated the Streptococcus pyogenes (Group A Streptococcus) vaccine development field, though scientific, regulatory and commercial barriers persist, and the vaccine pipeline remains sparse. There is an ongoing need to accelerate all aspects of development to address the la...
Autores principales: | Walkinshaw, Donald R., Wright, Meghan E. E., Mullin, Anne E., Excler, Jean-Louis, Kim, Jerome H., Steer, Andrew C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925938/ https://www.ncbi.nlm.nih.gov/pubmed/36788225 http://dx.doi.org/10.1038/s41541-023-00609-x |
Ejemplares similares
-
Safety of Streptococcus pyogenes Vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post-Marketing Monitoring
por: Asturias, Edwin J, et al.
Publicado: (2023) -
A Strep A vaccine global demand and return on investment forecast to inform industry research and development prioritization
por: Walkinshaw, Donald R., et al.
Publicado: (2023) -
Accelerating the development of a group A Streptococcus vaccine: an urgent public health need
por: Excler, Jean-Louis, et al.
Publicado: (2016) -
Streptococcus pyogenes: Pathogenesis and the Current Status of Vaccines
por: Wang, Jiachao, et al.
Publicado: (2023) -
Conserved and specific features of Streptococcus pyogenes and Streptococcus agalactiae transcriptional landscapes
por: Rosinski-Chupin, Isabelle, et al.
Publicado: (2019)